Postprandial vascular effects of VIAject compared with insulin lispro and regular human insulin in patients with type 2 diabetes

Diabetes Care

Volumn 33, Issue 1, 2010, Pages 116-120

  Forst, Thomas ^a   Pfützner, Andreas ^a   Flacke, Frank ^b   Krasner, Alan ^b   Hohberg, Cloth ^a   Tarakci, E D A ^a   Pichotta, Philip ^b   Forst, Senait ^a   Steiner, Solomon ^b  

^a Institute for Clinical Research and Development   (Germany)

^b Biodel Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; GLUCOSE; HEMOGLOBIN A1C; HUMAN INSULIN; INSULIN; INSULIN LISPRO; INSULIN VIAJECT; N(G),N(G) DIMETHYLARGININE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; ELASTICITY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; OXYGEN SATURATION; OXYGEN TISSUE LEVEL; SKIN BLOOD FLOW;

ARGININE; BLOOD GLUCOSE; BLOOD VESSELS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INJECTIONS, SUBCUTANEOUS; INSULIN; MALE; MICROCIRCULATION; MIDDLE AGED; POSTPRANDIAL PERIOD; TYROSINE;

EID: 74249105645     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc09-0411     Document Type: Article

References (25)

1. Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH Jr, Probstfield JL, Simons-Morton DG, Friedewald WT. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-2559
2. ADVANCE Collaborative Group, Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Liu L, Mancia G, Mogensen CE, Pan C, Poulter N, Rodgers A, Williams B, Bompoint S, de Galan BE, Joshi R, Travert F. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560-2572
3. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, Zieve FJ, Marks J, Davis SN, Hayward R, Warren SR, Goldman S, McCarren M, Vitek ME, Henderson WG, Huang GD; the VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009;360:129-139
4. Forst T, Kunt T, Pohlmann T, Goitom K, Löbig M, Engelbach M, Beyer J, Pfutzner A. Microvascular skin blood flow following the ingestion of 75g glucose in healthy individuals. Exp Clin Endocrinol Diabetes 1998;106:454-459
5. Forst T, Hohberg C, Pfützner A. Cardiovascular effects of disturbed insulin activity in metabolic syndrome and in type 2 diabetic patients. Horm Metab Res 2009;41:123-131
6. Liu Z. Insulin at physiological concentrations increases microvascular perfusion in human myocardium. Am J Physiol Endocrinol Metab 2007;293:E1250-E1255
7. Williams SB, Goldfine AB, Timimi FK, Ting HH, Roddy MA, Simonson DC, Creager MA. Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation 1998;97:1695-1701
8. Ceriello A, Quagliaro L, Piconi L, Assaloni R, Da Ros R, Maier A, Esposito K, Giugliano D. Effect of postprandial hypertriglyceridemia and hyperglycemia on circulating adhesion molecules and oxidative stress generation and the possible role of simvastatin treatment. Diabetes 2004;53:701-710
9. Forst T, Pohlmann T, Kazda Ch, Welter K, Langer F, Forst S, Pfutzner A. The impact of insulin lispro and regular insulin on postprandial endothelial function and microvascular blood flow in type 1 diabetic patients. Diabetes 2003;51(Suppl. 2):A292
10. Hohberg C, Forst T, Larbig M, Safinowski M, Diessel S, Hehenwarter S, Weber MM, Schöndorf T, Pfützner A. Effect of insulin glulisine on microvascular blood flow and endothelial function in the postprandial state. Diabetes Care 2008;31:1021-1025
11. Ceriello A, Cavarape A, Martinelli L, Da Ros R, Marra G, Quagliaro L, Piconi L, Assaloni R, Motz E. The post-prandial state in type 2 diabetes and endothelial dysfunction: effects of insulin aspart. Diabet Med 2004;21:171-175
12. Forst T, Hohberg C, Tarakci E, Forst S, Kann P, Pfützner A. Reliability of light-guide spectrophotometry (O2C) for the investigation of skin tissue microvascular blood flow and tissue oxygen supply in diabetic and non-diabetic subjects. J Diabetes Sci Technol 2008;2:1151-1156
13. Wilhelm B, Klein J, Friedrich Ch, Forst S, Pfützner A, Kann P, Weber M, Forst T. Increased arterial augmentation and augmentation index as surrogate parameters for arteriosclerosis in subjects with diabetes mellitus and non-diabetic subjects with cardiovascular disease. J Diabetes Sci Technol 2007;2:260-263
14. Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, Colette C. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 2006;295:1681-1687
15. Cavalot F, Petrelli A, Traversa M, Bonomo K, Fiora E, Conti M, Anfossi G, Costa G, Trovati M. Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga Diabetes Study. J Clin Endocrinol Metab 2006;91:813-819
16. Montagnani M, Quon MJ. Insulin action in vascular endothelium: potential mechanisms linking insulin resistance with hypertension. Diabetes Obes Metab 2000;2:285-292
17. Scognamiglio R, Negut C, de Kreutzenberg SV, Tiengo A, Avogaro A. Effects of different insulin regimes on postprandial myocardial perfusion defects in type 2 diabetic patients. Diabetes Care 2006;29:95-100
18. Marcovecchio ML, Widmer B, Dunger DB, Dalton RN. Effect of acute variations of insulin and glucose on plasma concentrations of asymmetric dimethylarginine in young people with type 1 diabetes. Clin Sci (Lond) 2008;115:361-369
19. Pereira EC, Ferderbar S, Bertolami MC, Faludi AA, Monte O, Xavier HT, Pereira TV, Abdalla DS. Biomarkers of oxidative stress and endothelial dysfunction in glucose intolerance and diabetes mellitus. Clin Biochem 2008;41:1454-1460
20. Miyazaki H, Matsuoka H, Cooke JP, Usui M, Ueda S, Okuda S, Imaizumi T. Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis. Circulation 1999;99:1141-1146
21. Fard A, Tuck CH, Donis JA, Sciacca R, Di Tullio MR, Wu HD, Bryant TA, Chen NT, Torres-Tamayo M, Ramasamy R, Berglund L, Ginsberg HN, Homma S, Cannon PJ. Acute elevations of plasma asymmetric dimethylarginine and impaired endothelial function in response to a high-fat meal in patients with type 2 diabetes. Arterioscler Thromb Vasc Biol 2000;20:2039-2044
22. Steiner S, Hompesch M, Pohl R, Simms P, Flacke F, Mohr T, Pfützner A, Heinemann L. A novel insulin formulation with a more rapid onset of action. Diabetologia 2008;51:1602-1606
23. Greenfield JR, Samaras K, Chisholm DJ, Campbell LV. Effect of postprandial insulinemia and insulin resistance on measurement of arterial stiffness (augmentation index). Int J Cardiol 2007;114:50-56
24. Wilhelm B, Weber MM, Kreisselmeier HP, Kugler M, Ries C, Pfützner A, Kann P, Forst T. Endothelial function and arterial stiffness in uncomplicated type 1 diabetes and healthy controls and the impact of insulin on these parameters during an euglycaemic clamp. J Diabetes Sci Technol 2007;582-589
25. Westerbacka J, Seppälä-Lindroos A, Yki-Järvinen H. Resistance to acute insulin induced decreases in large artery stiffness accompanies the insulin resistance syndrome. J Clin Endocrinol Metab 2001;86:5262-5268